{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:21:39Z","timestamp":1790752899411,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jare.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:18:46Z","timestamp":1469524726000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["New insights into HCV-related rheumatologic disorders: A review"],"prefix":"10.1016","volume":"8","author":[{"given":"Patrice","family":"Cacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clo\u00e9","family":"Comarmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 5","key":"10.1016\/j.jare.2016.07.005_b0005","first-page":"S158","article-title":"Epidemiology of hepatitis C in Europe","volume":"46","author":"Negro","year":"2014","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0010","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","article-title":"Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C","volume":"42","author":"Cacoub","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d\u2019Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l\u2019Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0168-8278(99)80239-6","article-title":"Extrahepatic manifestations of HCV infection: facts and controversies","volume":"31","author":"Zignego","year":"1999","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0025","first-page":"2","article-title":"Italian association of the study of liver commission on extrahepatic manifestations of HCV infection. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"suppl 1","key":"10.1016\/j.jare.2016.07.005_b0030","first-page":"S38","article-title":"Hepatitis C virus lymphotropism: lessons from a decade of studies","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0035","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"issue":"suppl 5","key":"10.1016\/j.jare.2016.07.005_b0040","first-page":"S165","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0045","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0050","first-page":"2199","article-title":"Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus","volume":"31","author":"Sene","year":"2004","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0055","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/art.30319","article-title":"Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis","volume":"63","author":"Terrier","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MD.0b013e3182a5cf71","article-title":"Life-threatening cryoglobulinemic patients with hepatitis C: clinical description and outcome of 279 patients","volume":"92","author":"Retamozo","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.amjcard.2012.09.028","article-title":"Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis","volume":"111","author":"Terrier","year":"2013","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0075","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1002\/art.21270","article-title":"Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"52","author":"Saadoun","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0080","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","article-title":"CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis","volume":"103","author":"Boyer","year":"2004","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.jare.2016.07.005_b0085","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0090","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/1529-0131(200109)44:9<2118::AID-ART364>3.0.CO;2-X","article-title":"Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia","volume":"44","author":"Cacoub","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/gene.2014.41","article-title":"Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis","volume":"15","author":"Zignego","year":"2014","journal-title":"Genes Immun"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0100","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.30274","article-title":"Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fc\u03b3 receptors","volume":"63","author":"Gragnani","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0105","doi-asserted-by":"crossref","first-page":"e62965","DOI":"10.1371\/journal.pone.0062965","article-title":"Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia","volume":"8","author":"Fognani","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0110","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0120","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus\u2013associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.23305","article-title":"Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response","volume":"58","author":"Landau","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"Peg-IFN\u03b1Ribavirin\/Protease inhibitor combination in severe hepatitis C virus associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun","year":"2015","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0135","first-page":"833","article-title":"Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study","volume":"46","author":"Gragnani","year":"2014","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","author":"European Association for Study of Liver","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0145","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","article-title":"Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study","volume":"75","author":"Saadoun","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jare.2016.07.005_b0150","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-215293","article-title":"Successful treatment of hepatitis C, genotype 3, with sofosbuvir\/ledipasvir in decompensated cirrhosis complicated by mixed cryoglobulinaemia","author":"Flemming","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jare.2016.07.005_b0155","article-title":"Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: preliminary results of a prospective pilot study","volume":"17","author":"Gragnani","year":"2016","journal-title":"Curr Drug Targets"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatol Baltim Md"},{"issue":"12","key":"10.1016\/j.jare.2016.07.005_b0165","first-page":"3054","article-title":"Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis","volume":"19","author":"Roccatello","year":"2004","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0170","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/ard.2007.081653","article-title":"Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis","volume":"67","author":"Saadoun","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0175","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","article-title":"Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20","volume":"101","author":"Sansonno","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0180","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","article-title":"Efficacy and safety of rituximab in type II mixed cryoglobulinemia","volume":"101","author":"Zaja","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0185","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/ard.2006.065565","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?","volume":"67","author":"Cacoub","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.34331","article-title":"A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.34322","article-title":"A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis","volume":"64","author":"Sneller","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0200","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/acr.21990","article-title":"Kinetic profiles and management of hepatitis B virus reactivation in patients with immune-mediated inflammatory diseases","volume":"65","author":"Droz","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0210","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/BOR.0b013e3282f1330c","article-title":"Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis","volume":"20","author":"Saadoun","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0220","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/acr.21856","article-title":"Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma","volume":"65","author":"Saadoun","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1994.03520050033023","article-title":"Non-Hodgkin\u2019s lymphoma: possible role of hepatitis C virus","volume":"272","author":"Ferri","year":"1994","journal-title":"JAMA J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0230","first-page":"1591","article-title":"Hepatitis C virus infection and B-cell lymphomas","volume":"30A","author":"Ferri","year":"1994","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0235","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0240","first-page":"2078","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin\u2019s lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.20205","article-title":"B-cell non-Hodgkin\u2019s lymphoma and hepatitis C virus infection: a systematic review","volume":"111","author":"Negri","year":"2004","journal-title":"Int J Cancer J Int Cancer"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0255","first-page":"451","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0260","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-129-4-199808150-00005","article-title":"Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection","volume":"129","author":"Andreone","year":"1998","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.jare.2016.07.005_b0265","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjmed.2007.06.022","article-title":"Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C","volume":"120","author":"Kawamura","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0270","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1182\/blood.V99.6.2259","article-title":"Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia","volume":"99","author":"Casato","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0275","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0285","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0290","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jare.2016.07.005_b0295","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2007.085910","article-title":"The B lymphocyte stimulator receptor-ligand system in hepatitis C virus-induced B cell clonal disorders","volume":"68","author":"Landau","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0305","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/ajcp\/109.5.508","article-title":"Hepatitis C virus and non-Hodgkin\u2019s lymphoma","volume":"109","author":"Lai","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0310","first-page":"3594","article-title":"Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia","volume":"160","author":"Sansonno","year":"1998","journal-title":"J Immunol Baltim Md 1950"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0315","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1002\/art.20594","article-title":"Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection","volume":"50","author":"Vallat","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"5390","key":"10.1016\/j.jare.2016.07.005_b0320","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0325","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2013-10-532895","article-title":"B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins","volume":"123","author":"Ng","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0330","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De Re","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0335","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/infdis\/171.3.672","article-title":"Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C","volume":"171","author":"Galli","year":"1995","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0340","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","article-title":"Infection of peripheral mononuclear blood cells by hepatitis C virus","volume":"15","author":"Zignego","year":"1992","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0345","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hep.510280127","article-title":"Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice","volume":"28","author":"Bronowicki","year":"1998","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0350","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.jare.2016.07.005_b0355","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"10.1016\/j.jare.2016.07.005_b0360","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2010-05-283358","article-title":"Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo","volume":"116","author":"Kasama","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jare.2016.07.005_b0365","first-page":"167501","article-title":"Hepatitis C virus-related lymphomagenesis in a mouse model","author":"Tsukiyama-Kohara","year":"2011","journal-title":"ISRN Hematol"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0370","first-page":"711","article-title":"Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases","volume":"15","author":"Zignego","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0375","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.510310230","article-title":"T(14;18) translocation in chronic hepatitis C virus infection","volume":"31","author":"Zignego","year":"2000","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0380","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21132","article-title":"Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment","volume":"43","author":"Giannini","year":"2006","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0385","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1182\/blood-2007-09-112490","article-title":"Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia","volume":"111","author":"Giannini","year":"2008","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0390","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.4161\/cbt.4.11.2087","article-title":"Elevated serum levels of osteopontin in HCV-associated lymphoproliferative disorders","volume":"4","author":"Libra","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0395","first-page":"1305","article-title":"Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders","volume":"15","author":"Libra","year":"2006","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0400","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/art.22456","article-title":"Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy","volume":"56","author":"Saadoun","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0405","first-page":"6013","article-title":"Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage","volume":"183","author":"Sansonno","year":"2009","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0410","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation\u2013the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"S\u00e8ne","year":"2007","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0415","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.autrev.2008.05.005","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?","volume":"8","author":"De Vita","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0420","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2008-07-170613","article-title":"Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?","volume":"112","author":"Giannini","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0425","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/leu.2012.29","article-title":"Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection","volume":"26","author":"Peveling-Oberhag","year":"2012","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0430","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.leu.2403443","article-title":"Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas","volume":"18","author":"Kelaidi","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0435","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin\u2019s lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0440","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2008.07565.x","article-title":"Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas","volume":"145","author":"Mazzaro","year":"2009","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0445","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0450","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1182\/blood.V88.2.752.bloodjournal882752","article-title":"Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists?","volume":"88","author":"Musto","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0455","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin\u2019s lymphoma","volume":"49","author":"La Mura","year":"2008","journal-title":"J Hepatol"},{"issue":"20","key":"10.1016\/j.jare.2016.07.005_b0460","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2002.08.674","article-title":"Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin\u2019s lymphoma","volume":"20","author":"Hainsworth","year":"2002","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.jare.2016.07.005_b0465","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.57.12.728","article-title":"Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection","volume":"57","author":"Lee","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200101000-00001","article-title":"Hepatitis C virus infection mimicking primary Sj\u00f6gren syndrome. A clinical and immunologic description of 35 cases","volume":"80","author":"Ramos-Casals","year":"2001","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0475","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2796.1999.00414.x","article-title":"Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sj\u00f6gren\u2019s syndrome and hepatitis C in Swedish patients","volume":"245","author":"Verbaan","year":"1999","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0480","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1073\/pnas.94.1.233","article-title":"Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes","volume":"94","author":"Koike","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0485","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0490","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1572-0241.1999.01447.x","article-title":"Anticardiolipin antibodies in patients with liver disease","volume":"94","author":"Mangia","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0495","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0500","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2215\/CJN.00470107","article-title":"Hepatitis C virus infection and the prevalence of renal insufficiency","volume":"2","author":"Dalrymple","year":"2007","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0505","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/j.ajkd.2012.08.040","article-title":"Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease","volume":"61","author":"Fabrizi","year":"2013","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0510","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.ajkd.2010.09.023","article-title":"HCV infection and the incidence of CKD","volume":"57","author":"Butt","year":"2011","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.2006.01686.x","article-title":"Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?","volume":"260","author":"Huang","year":"2006","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0520","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2010.01.015","article-title":"Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study","volume":"56","author":"Lee","year":"2010","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00080.x","article-title":"Relationship between hepatitis C and microalbuminuria: results from the NHANES III","volume":"67","author":"Liangpunsakul","year":"2005","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.jare.2016.07.005_b0530","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32830e0152","article-title":"The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis","volume":"22","author":"Wyatt","year":"2008","journal-title":"AIDS Lond Engl"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0535","first-page":"509","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0540","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/cir306","article-title":"All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population","volume":"53","author":"El-Kamary","year":"2011","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0545","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1017\/S0950268805005340","article-title":"Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure","volume":"134","author":"Harris","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0550","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0555","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0560","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/hep.23002","article-title":"Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study","volume":"50","author":"Uto","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0565","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/apt.12485","article-title":"The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010","volume":"38","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpg.2012.09.009","article-title":"Natural history of acute and chronic hepatitis C","volume":"26","author":"Maasoumy","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0575","first-page":"71","article-title":"Increased mortality among persons infected with hepatitis C virus","volume":"9","author":"Omland","year":"2011","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0580","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro","year":"2015","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.jare.2016.07.005_b0585","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/hc0902.105718","article-title":"Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers","volume":"105","author":"Ishizaka","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jare.2016.07.005_b0590","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.STR.0000089015.51603.CC","article-title":"Inflammation and infections as risk factors for ischemic stroke","volume":"34","author":"Lindsberg","year":"2003","journal-title":"Stroke J Cereb Circ"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0595","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157016109787455707","article-title":"Infection, its treatment and the risk for stroke","volume":"7","author":"Palm","year":"2009","journal-title":"Curr Vasc Pharmacol"},{"issue":"1 Suppl","key":"10.1016\/j.jare.2016.07.005_b0600","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro","year":"2014","journal-title":"J Hepatol"},{"issue":"13","key":"10.1016\/j.jare.2016.07.005_b0605","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3748\/wjg.v20.i13.3410","article-title":"Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms","volume":"20","author":"Adinolfi","year":"2014","journal-title":"World J Gastroenterol WJG"},{"issue":"11","key":"10.1016\/j.jare.2016.07.005_b0610","doi-asserted-by":"crossref","first-page":"e81305","DOI":"10.1371\/journal.pone.0081305","article-title":"Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis","volume":"8","author":"He Huang","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0615","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0620","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis C virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2009","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0625","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2012.07.045","article-title":"Myocardial injury in patients with chronic hepatitis C infection","volume":"58","author":"Maruyama","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0630","first-page":"621","article-title":"Chronic hepatitis C virus infection, a new cardiovascular risk factor?","volume":"36","author":"Domont","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"107\u2013108","key":"10.1016\/j.jare.2016.07.005_b0635","first-page":"875","article-title":"Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C","volume":"58","author":"Taskoparan","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0640","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.25867","article-title":"Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C","volume":"56","author":"Aghemo","year":"2012","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.jare.2016.07.005_b0645","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3851\/IMP1298","article-title":"Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV-hepatitis C virus-coinfected patients: HOMAVIC-ANRS HC02 Study","volume":"14","author":"Cacoub","year":"2009","journal-title":"Antivir Ther"},{"issue":"Suppl 2","key":"10.1016\/j.jare.2016.07.005_b0650","first-page":"13","article-title":"Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data","volume":"29","author":"Serfaty","year":"2009","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"7","key":"10.1016\/j.jare.2016.07.005_b0655","first-page":"1480","article-title":"Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection","volume":"91","author":"Ozyilkan","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0660","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2796.1994.tb01075.x","article-title":"Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus","volume":"235","author":"Ozyilkan","year":"1994","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.jare.2016.07.005_b0690","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar3865","article-title":"Current treatment of hepatitis C-associated rheumatic diseases","volume":"14","author":"Ferri","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jare.2016.07.005_b0665","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/hep.510300416","article-title":"Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection","volume":"30","author":"Caronia","year":"1999","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"10.1016\/j.jare.2016.07.005_b0670","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.510290235","article-title":"Association of diabetes mellitus and chronic hepatitis C virus infection","volume":"29","author":"Mason","year":"1999","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0675","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rdc.2009.03.005","article-title":"Hepatitis C-associated rheumatic disorders","volume":"35","author":"Buskila","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.jare.2016.07.005_b0680","first-page":"287","article-title":"Hepatitis C virus infection and its rheumatologic implications","volume":"10","author":"Sayiner","year":"2014","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jare.2016.07.005_b0685","doi-asserted-by":"crossref","first-page":"e000008","DOI":"10.1136\/rmdopen-2014-000008","article-title":"For patients with rheumatic disease and hepatitis C infection: the end of interferon","volume":"1","author":"Calabrese","year":"2015","journal-title":"RMD Open"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123216300534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:42:00Z","timestamp":1761856920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123216300534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":138,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2090123216300534"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2016.07.005","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into HCV-related rheumatologic disorders: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Production and hosting by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}